Novel Aspects Pertaining to the Relationship of Waldenström's Macroglobulinemia, IgM Monoclonal Gammopathy of Undetermined Significance, Polyclonal Gammopathy, and Hypoglobulinemia
- 1 March 2009
- journal article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 9 (1), 19-22
- https://doi.org/10.3816/clm.2009.n.003
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia patients: a population-based study in SwedenBlood, 2008
- Chronic Immune Stimulation and Subsequent Waldenström MacroglobulinemiaJAMA Internal Medicine, 2008
- Prevalence of Monoclonal Gammopathy of Undetermined Significance: Study of 52,802 Persons in Nagasaki City, JapanMayo Clinic Proceedings, 2007
- Prevalence of Monoclonal Gammopathy of Undetermined Significance Among Men in GhanaMayo Clinic Proceedings, 2007
- Protein electrophoresis, immunoelectrophoresis and immunofixation electrophoresis as predictors for high-risk phenotype in familial Waldenström macroglobulinemiaInternational Journal of Cancer, 2007
- Genomewide Linkage Screen for Waldenström Macroglobulinemia Susceptibility Loci in High-Risk FamiliesAmerican Journal of Human Genetics, 2006
- Familial Waldenstrom's macroglobulinemiaSeminars in Oncology, 2003
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceThe New England Journal of Medicine, 2002
- Waldenström's macroglobulinemia*Cancer, 1998
- Frequency of Pathological Proteins (M‐components) in 6,995 Sera from an Adult PopulationActa Medica Scandinavica, 1966